What is the appropriate workup to confirm Graves disease in a patient with hyperthyroidism?

Workup to Confirm Graves Disease in Hyperthyroidism

In a patient with confirmed hyperthyroidism, measure TSH receptor antibodies (TRAb) as the first-line test—this has near 100% sensitivity and specificity for Graves disease and makes other etiological examinations unnecessary in most cases. 1

Step-by-Step Diagnostic Algorithm

1. Confirm Biochemical Hyperthyroidism First

• Measure TSH (will be suppressed below laboratory lower limit)
• If TSH is low, measure free T4
• If free T4 is normal despite low TSH, add free T3 to detect T3-predominant hyperthyroidism 1

2. Determine the Etiology with TRAb Testing

For typical presentations (young female, homogeneous goiter, ophthalmopathy):

• TRAb testing alone is sufficient—no other tests are mandatory for diagnosis 1
• Modern second-generation TRAb assays have approximately 95-100% sensitivity and specificity 2, 3
• Positive TRAb confirms Graves disease with near 100% positive predictive value 1

For atypical presentations (older patients, nodular goiter, no eye signs):

• Start with TRAb as first-line test 1, 4
• If TRAb is negative, proceed to thyroid scintigraphy (see below)

3. Additional Testing When TRAb is Negative or Unavailable

If TRAb results cannot be obtained rapidly or are negative:

Thyroid scintigraphy with technetium-99m uptake (TcTU):

• Most accurate method overall (96% diagnostic accuracy) 2, 4
• TcTU ≥1.3% indicates Graves disease with 95.3% sensitivity and 96.4% specificity 2
• Reserve this for TRAb-negative patients to avoid unnecessary radiation exposure 2

Thyroid ultrasound with Doppler:

• Less accurate than TRAb or scintigraphy (77% accuracy) 4
• "Thyroid inferno" pattern (echo pattern 3) has high positive predictive value (95.2%) but lower specificity (69.8%) 2
• Useful when scintigraphy is contraindicated or unavailable

Anti-TPO antibodies:

• Only if TRAb is negative—helps identify autoimmune thyroiditis as alternative diagnosis 1
• Does not distinguish Graves from other causes of hyperthyroidism

Important Clinical Caveats

When TRAb May Be Misleading:

• TRAb-negative Graves disease exists in approximately 5-12% of cases 3, 5, 4
• False positives can occur in non-Graves hyperthyroidism, particularly in amiodarone-induced thyrotoxicosis 4
• Atypical Graves disease presentations may show spontaneous remission or unusual uptake patterns 5

Practical Considerations:

• Second-generation TRAb assays (measured in IU/L) are superior to first-generation assays (measured in U/L) 6
• Optimal TRAb cutoff is 0.7 IU/L for Kryptor assay and 0.1 IU/L for Immulite assay 2
• Clinical diagnosis alone has only 88% sensitivity and 66% specificity—objective testing is essential 3

Special Populations:

• In pregnancy, TRAb testing is critical as scintigraphy is contraindicated 7
• TRAb levels >10 IU/L at 6 months predict poor response to antithyroid drugs 6

Summary of Test Hierarchy

1. TRAb (first-line, ~95-100% accuracy)
2. Thyroid scintigraphy (if TRAb negative/unavailable, ~96% accuracy)
3. Thyroid ultrasound with Doppler (adjunctive, ~77% accuracy)
4. Anti-TPO (only if TRAb negative, to identify alternative autoimmune cause)

The key principle: TRAb positivity in the setting of biochemical hyperthyroidism essentially confirms Graves disease, eliminating the need for imaging in most cases. Reserve scintigraphy for the minority of TRAb-negative patients where diagnostic uncertainty remains 1, 2, 4.